Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) Through Multi-Kinase Inhibition

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-1928
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Multimodal Molecular Analysis of an Atypical Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Cold Spring Harbor molecular case studies
BiochemistryMolecular MedicineGenetics
2018English

Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Displays Frequent Inactivating Germline and Somatic Mutations in SMARCA4

Nature Genetics
Genetics
2014English

Histone Deacetylase Inhibitors Synergizes With Catalytic Inhibitors of EZH2 to Exhibit Anti-Tumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Successful Treatment of a Stage IIIC Small-Cell Carcinoma of the Ovary Hypercalcemic Subtype Using Multi-Modality Therapeutic Approach

ecancermedicalscience
Cancer ResearchOncology
2018English

TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Artesunate Shows Potent Anti-Tumor Activity in B-Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Ovarian Small Cell Carcinoma of Hypercalcemic Type – Evidence of Germline Origin and Smarca4 Gene Inactivation. A Pilot Study

Polish Journal of Pathology
MedicineForensic MedicinePathology
2013English

Selective Inhibition of BCL2 Shows Antitumor Effects in Lung Cancer

Cancer Discovery
Oncology
2015English

Combined Aurora Kinase a (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy